Verified Peptide ReviewLast reviewed: 24 April 2026
Compound Profile · Immune
Larazotide
Larazotide is a synthetic octapeptide studied in research for tight-junction modulation and intestinal barrier function in coeliac and inflammatory bowel contexts.
LegalResearch onlyEvidenceEmergingHuman useNot approved
7.2/ 10
Peptide Score
Evidence
Safety
Regulatory
Transparency
Quick verdict
Investigational tight-junction modulator with emerging clinical evidence. Development is ongoing.
Reality check
What this isn't
- Not approved for human use — research-only context
- No regulator has approved human use
- Evidence base is early — long-term data limited
- Side-effect profile not fully characterised
- Educational only — not medical advice
Full Larazotide review
A synthetic octapeptide derived from zonula occludens toxin.
Studied for tight-junction stabilisation and intestinal barrier function.
Looking at alternatives?
Compounds with comparable research interest but different evidence, regulatory status, or risk profile.